Drug therapy of primary biliary diseases: classical and modern strategies. (Q34687676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Drug therapy of primary biliary diseases: classical and modern strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

J Schlichting

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

U Leuschner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular and Molecular Medicine

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

98-115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

Update on primary biliary cirrhosis

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Etiology and natural history of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Ursodeoxycholate stabilizes phospholipid-rich membranes and mimics the effect of cholesterol: investigations on large unilamellar vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Colchicine treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Surgical treatment for primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Early detection and treatment of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Prevention of bile duct cancer in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Liver transplantation for cholangiocarcinoma: results in 207 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Treatment of pruritus of primary biliary cirrhosis with rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Vitamin D receptor polymorphism and posttransplantation bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Calcitriol for bone disease in patients with cirrhosis of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

FK506, an immunosuppressant targeting calcineurin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

An open-label pilot trial of cladibrine (2-cholordeoxyadenosine) in patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Combined Therapy with Azathioprine, Prednisolone, and Ursodiol in Patients with Primary Sclerosing Cholangitis: A Case Series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2001.TB00144.X

Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study

21 January 2018

1 reference

12 December 2020

Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease

1 reference

12 December 2020

Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression

1 reference

12 December 2020

Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data

1 reference

12 December 2020

Non-invasive assessment of bone density in primary biliary cirrhosis.

1 reference

12 December 2020

The Fifth Carlos E. Rubio Memorial Lecture. Sclerosing cholangitis: pathogenesis, pathology, and practice

1 reference

12 December 2020

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group

1 reference

12 December 2020

Newer immunosuppressive drugs: a review.

1 reference

12 December 2020

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial

1 reference

12 December 2020

Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis

1 reference

12 December 2020

1 reference

12 December 2020

Genetic susceptibility to primary biliary cirrhosis.

1 reference

12 December 2020

Evidence-based therapy of primary biliary cirrhosis

1 reference

12 December 2020

Prevention and treatment of osteoporosis in primary biliary cirrhosis

1 reference

12 December 2020

The pathogenesis and treatment of pruritus and fatigue in patients with PBC.

1 reference

12 December 2020

Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol

1 reference

12 December 2020

Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial

1 reference

12 December 2020

Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study

1 reference

12 December 2020

Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis

1 reference

12 December 2020

Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial

1 reference

12 December 2020

Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis

1 reference

12 December 2020

A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Time course of histological progression in primary sclerosing cholangitis.

1 reference

12 December 2020

Low-dose methotrexate in primary biliary cirrhosis

1 reference

12 December 2020

Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile

1 reference

12 December 2020

Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study

1 reference

12 December 2020

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

1 reference

12 December 2020

Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation

1 reference

12 December 2020

CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

12 December 2020

Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development

1 reference

12 December 2020

Osteoporosis prevention and treatment

1 reference

12 December 2020

Maintenance immunosuppression: new agents and persistent dilemmas

1 reference

12 December 2020

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

12 December 2020

Primary sclerosing cholangitis

1 reference

12 December 2020

Liver transplantation for primary sclerosing cholangitis

1 reference

12 December 2020

Clinical pharmacology of immunosuppressive drugs: year 2000--time for alternatives

1 reference

12 December 2020

Cholestatic hepatopathy: primary biliary cirrhosis

1 reference

12 December 2020

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group

1 reference

12 December 2020

Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma

1 reference

12 December 2020

Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid

1 reference

12 December 2020

Sirolimus: continuing the evolution of transplant immunosuppression

1 reference

12 December 2020

Oral budesonide in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid

1 reference

12 December 2020

1 reference

12 December 2020

Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial

1 reference

12 December 2020

Different approaches to bone densitometry.

1 reference

12 December 2020

Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis

1 reference

12 December 2020

A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results

1 reference

12 December 2020

Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study

1 reference

12 December 2020

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

1 reference

12 December 2020

Combination therapy with ursodeoxycholic acid and colchicine for primary biliary cirrhosis

1 reference

12 December 2020

Immunomodulatory effects of ursodeoxycholic acid on immune responses

1 reference

12 December 2020

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Treatment of primary biliary cirrhosis with low-dose weekly methotrexate

1 reference

12 December 2020

Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy.

1 reference

12 December 2020

Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

The combination of prednisone and colchicine in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Treatment of primary sclerosing cholangitis with oral methotrexate

1 reference

12 December 2020

Relationship of inflammatory bowel disease and primary sclerosing cholangitis

1 reference

12 December 2020

Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment

1 reference

12 December 2020

A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study

1 reference

12 December 2020

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

12 December 2020

A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss

1 reference

12 December 2020

Evaluation of colchicine therapy in primary biliary cirrhosis

1 reference

12 December 2020

Randomized trial of chlorambucil for primary biliary cirrhosis.

1 reference

12 December 2020

A prospective trial of colchicine for primary biliary cirrhosis

1 reference

12 December 2020

A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report

1 reference

12 December 2020

Effects of penicillamine on serum immunoglobulins and immune complex-reactive material in primary biliary cirrhosis

1 reference

12 December 2020

Trial of penicillamine in advanced primary biliary cirrhosis

1 reference

12 December 2020

Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial

1 reference

12 December 2020

Azathioprine treatment in primary sclerosing cholangitis

1 reference

12 December 2020

The late results of long-term treatment of primary biliary cirrhosis by corticosteroids

1 reference

12 December 2020

Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial

1 reference

12 December 2020

Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial

1 reference

12 December 2020

The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study

1 reference

12 December 2020

Fatigue associated with chronic liver disease: a riddle wrapped in a mystery inside an enigma

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.

1 reference

12 December 2020

A prospective controlled trial of azathioprine in primary biliary cirrhosis

1 reference

12 December 2020

Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis

1 reference

12 December 2020

Pharmacology of ursodeoxycholic acid, an enterohepatic drug.

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?

1 reference

12 December 2020

Successful treatment of primary sclerosing cholangitis with cyclosporine and corticosteroid

1 reference

12 December 2020

Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis

1 reference

12 December 2020

Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a short-term, randomized, double-blind controlled, cross-over study with long-term follow up

1 reference

12 December 2020

Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

1 reference

12 December 2020

Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis

1 reference

12 December 2020

A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Molecular aspects of membrane stabilization by ursodeoxycholate [see comment]

1 reference

12 December 2020

Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial

1 reference

12 December 2020

Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: a comparison of complications and outcome.

1 reference

12 December 2020

Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.

1 reference

12 December 2020

Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes

1 reference

12 December 2020

Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis

1 reference

12 December 2020

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

1 reference

12 December 2020

Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study

1 reference

12 December 2020

Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis

1 reference

12 December 2020

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopathological factors

1 reference

12 December 2020

Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis

1 reference

12 December 2020

Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period.

1 reference

12 December 2020

Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei

1 reference

12 December 2020

Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment

1 reference

12 December 2020

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

12 December 2020

Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study

1 reference

12 December 2020

Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study

1 reference

12 December 2020

The clinical expression of primary biliary cirrhosis

1 reference

12 December 2020

Primary sclerosing cholangitis: evolving concepts in diagnosis and treatment

1 reference

12 December 2020

Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years

1 reference

12 December 2020

The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone

1 reference

12 December 2020

Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases

1 reference

12 December 2020

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

1 reference

12 December 2020

Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis

1 reference

12 December 2020

Bone disorders in cholestatic liver diseases

1 reference

12 December 2020

The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences

1 reference

12 December 2020

A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation

1 reference

12 December 2020

Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis

1 reference

12 December 2020

The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis

1 reference

12 December 2020

A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.

1 reference

12 December 2020

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

1 reference

12 December 2020

Three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine

1 reference

12 December 2020

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

1 reference

12 December 2020

A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group

1 reference

12 December 2020

Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis

1 reference

12 December 2020

Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications

1 reference

12 December 2020

Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study

1 reference

12 December 2020

Novel therapeutic approach to primary biliary cirrhosis patients: anti-eosinophil strategy

1 reference

12 December 2020

New immunosuppressive strategies

1 reference

12 December 2020

10.1111/J.1582-4934.2001.TB00144.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12067457%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference